VANCOUVER, British Columbia — Life Sciences BC (LSBC) is pleased to announce its Board of Directors following its Annual General Meeting (AGM) on October 15, 2026. The Board of Directors is comprised of life sciences leaders dedicated to driving forward the growth of life sciences in British Columbia and represent diverse perspectives across the sector.
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
LSBC announced the following Board Members who were re-elected as Director for a 3-year term: Rajveer Hundal, Partner, PwC Canada; Lana Janes, Chief Scientific Officer, CPDC (Centre for Probe Development and Commercialization); David Poon, Co-Founder & Head of Corporate Development, DCx Biotherapeutics; Scott Phillips, President, Starfish Medical; and Peter Zandstra, VP, Research and Innovation, University of British Columbia.
At the Board Meeting following the AGM, Joseph Garcia, Partner, Blake, Cassels & Graydon LLP, and Roger Kuypers, Partner, Fasken, Martineau, Dumoulin LLP received renewed one-year appointments as Board Observers.
Get the latest headlines, breaking news and columns.
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
A welcome email is on its way. If you don't see it, please check your junk folder.
The next issue of Top Stories will soon be in your inbox.
We encountered an issue signing you up. Please try again
The full slate of LSBC’s Board of Directors is listed below. To learn more about our current board members, please visit our website.
- Board Chair: Lana Janes, Chief Scientific Officer, CPDC (Centre for Probe Development and Commercialization)
- Past Chair: Anne Stevens, Life Sciences Executive (former VP, Business Development, AbCellera)
- Treasurer: Rajveer Hundal, Partner, PwC Canada
- Sherry Aulin, Life Sciences Executive Leader (former CFO, Xenon)
- Kevin Chaplin, CEO, Kardium
- Tom Frohlich, CEO, Jade Biosciences
- Wendy Hurlburt, President & CEO, Life Sciences BC
- Michael Martin, Global Biopharmaceutical Executive (former COO, Aurinia)
- Scott Phillips, President, Starfish Medical
- David Poon, Co-Founder, Head of Corporate Development, DCx Biotherapeutics
- Sandra Wong, Senior Manager, Access and Government Affairs, Pfizer Canada
- Christina Zacharuk, CEO, Research Universities’ Council of British Columbia
- Peter Zandstra, VP, Research and Innovation, University of British Columbia
- Joseph Garcia, Partner, Blake, Cassels & Graydon LLP
- Roger Kuypers, Partner, Fasken, Martineau, Dumoulin LLP
LSBC would like to thank our outgoing Board Directors and Observer for their service and leadership over the past years.
- Ali Ardakani, Founder & Managing Director, Novateur Ventures, Co-Founder & CEO of Optigo Biotherapeutics, LSBC Board Director for nine years including two as Board Chair
- Suzanne Gill, Life Sciences Executive, LSBC Board Director for four years
- David Helliwell, Co-Founder & Executive Board Chair, Thrive Health, LSBC Board Director for six years
- Hector MacKay-Dunn, KC, Senior Partner, Farris, Vaughan, Wills & Murphy LLP, LSBC Board Observer for many years
Life Sciences BC (LSBC) is a not-for-profit sector association dedicated to advancing British Columbia’s life sciences ecosystem through strategic initiatives at the local, national, and international levels. We drive economic growth in the province by providing leadership, fostering investment and partnerships, collaborating with government, and promoting BC’s world-class life sciences sector.
Contacts
Rosabel Bong
Manager, Marketing & Communications
Email:
Join the Conversation
This website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.